{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:49:29Z","timestamp":1789469369800,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jbc.2023.102971","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T02:14:50Z","timestamp":1675217690000},"page":"102971","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Acetylation stabilizes the signaling protein WISP2 by preventing its degradation to suppress the progression of acute myeloid leukemia"],"prefix":"10.1016","volume":"299","author":[{"given":"Hao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinying","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2023.102971_bib1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.exphem.2009.04.002","article-title":"Acute myelogenous leukemia","volume":"37","author":"Shipley","year":"2009","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.jbc.2023.102971_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.beha.2012.10.005","article-title":"Can we improve outcomes in patients with acute myelogenous leukemia? Incorporating HDAC inhibitors into front-line therapy","volume":"25","author":"Garcia-Manero","year":"2012","journal-title":"Best Practice Res. Clin. Haematol."},{"key":"10.1016\/j.jbc.2023.102971_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41375-020-01069-1","article-title":"New strategies to treat AML: novel insights into AML survival pathways and combination therapies","volume":"35","author":"Nair","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2023.102971_bib4","doi-asserted-by":"crossref","first-page":"114253","DOI":"10.1016\/j.bcp.2020.114253","article-title":"Targeting mitochondrial respiration for the treatment of acute myeloid leukemia","volume":"182","author":"Carter","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jbc.2023.102971_bib5","doi-asserted-by":"crossref","first-page":"14717","DOI":"10.1073\/pnas.95.25.14717","article-title":"WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors","volume":"95","author":"Pennica","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.102971_bib6","first-page":"189","article-title":"The connective tissue growth factor\/cysteine-rich 61\/nephroblastoma overexpressed (CCN) family","volume":"20","author":"Brigstock","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jbc.2023.102971_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0083-6729(05)70003-0","article-title":"Structural and functional properties of CCN proteins","volume":"70","author":"Rachfal","year":"2005","journal-title":"Vitamins Horm."},{"key":"10.1016\/j.jbc.2023.102971_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2007.02.012","article-title":"Loss of WISP-2\/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition","volume":"254","author":"Dhar","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2023.102971_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/molehr\/gah028","article-title":"The growth arrest-specific gene CCN5 is deficient in human leiomyomas and inhibits the proliferation and motility of cultured human uterine smooth muscle cells","volume":"10","author":"Mason","year":"2004","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.jbc.2023.102971_bib10","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/bjc.2015.285","article-title":"WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-\u03b3 pathways","volume":"113","author":"Ji","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jbc.2023.102971_bib11","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1245\/s10434-007-9376-x","article-title":"Differential expression and prognostic implications of the CCN family members WISP-1, WISP-2, and WISP-3 in human breast cancer","volume":"14","author":"Davies","year":"2007","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jbc.2023.102971_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1476-5586(03)80018-0","article-title":"WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation","volume":"5","author":"Banerjee","year":"2003","journal-title":"Neoplasia"},{"key":"10.1016\/j.jbc.2023.102971_bib13","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jbc.2023.102971_bib14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2217\/epi.11.73","article-title":"Epigenomics of leukemia: from mechanisms to therapeutic applications","volume":"3","author":"Florean","year":"2011","journal-title":"Epigenomics"},{"key":"10.1016\/j.jbc.2023.102971_bib15","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1158\/1078-0432.CCR-04-0210","article-title":"Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3","volume":"10","author":"Bali","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2023.102971_bib16","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1038\/sj.leu.2404860","article-title":"The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in\u00a0vitro and in\u00a0vivo and inhibits IL-6 and VEGF production by stromal cells","volume":"21","author":"Golay","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2023.102971_bib17","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1158\/1078-0432.CCR-19-0171","article-title":"Histone deacetylase inhibition with panobinostat combined with intensive induction chemotherapy in older patients with acute myeloid leukemia: phase I study results","volume":"25","author":"Wieduwilt","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2023.102971_bib18","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.drudis.2009.06.008","article-title":"Histone acetyl transferases as emerging drug targets","volume":"14","author":"Dekker","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jbc.2023.102971_bib19","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrg2485","article-title":"The many roles of histone deacetylases in development and physiology: implications for disease and therapy","volume":"10","author":"Haberland","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jbc.2023.102971_bib20","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/nbt849","article-title":"A\u00a0proteomics approach to understanding protein ubiquitination","volume":"21","author":"Peng","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jbc.2023.102971_bib21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41580-018-0081-3","article-title":"Functions and mechanisms of non-histone protein acetylation","volume":"20","author":"Narita","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jbc.2023.102971_bib22","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/onc.2011.347","article-title":"Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation","volume":"31","author":"Wang","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2023.102971_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2019.11.043","article-title":"Acetylation of alpha-fetoprotein promotes hepatocellular carcinoma progression","volume":"471","author":"Xue","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jbc.2023.102971_bib24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s10147-013-0550-9","article-title":"A\u00a0comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell\/adenosquamous carcinomas and adenocarcinoma of the gallbladder","volume":"19","author":"Yang","year":"2014","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.jbc.2023.102971_bib25","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1128\/MCB.01335-07","article-title":"Role of WISP-2\/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells","volume":"28","author":"Fritah","year":"2008","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jbc.2023.102971_bib26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1158\/1541-7786.MCR-04-0130","article-title":"Epidermal growth factor induces WISP-2\/CCN5 expression in estrogen receptor-alpha-positive breast tumor cells through multiple molecular cross-talks","volume":"3","author":"Banerjee","year":"2005","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbc.2023.102971_bib27","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.celrep.2013.05.024","article-title":"PLK1 signaling in breast cancer cells cooperates with estrogen receptor-dependent gene transcription","volume":"3","author":"Wierer","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.jbc.2023.102971_bib28","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/onc.2011.417","article-title":"Non-canonical HIF-2\u03b1 function drives autonomous breast cancer cell growth via an AREG-EGFR\/ErbB4 autocrine loop","volume":"31","author":"Stiehl","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2023.102971_bib29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s12031-014-0359-7","article-title":"Transcriptional regulation by FOXP1, FOXP2, and FOXP4 dimerization","volume":"55","author":"Sin","year":"2015","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.jbc.2023.102971_bib30","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1242\/jcs.197764","article-title":"miR-450a-5p within rat adipose tissue exosome-like vesicles promotes adipogenic differentiation by targeting WISP2","volume":"130","author":"Zhang","year":"2017","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.jbc.2023.102971_bib31","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1158\/0008-5472.CAN-09-0155","article-title":"MicroRNA signature of primary pigmented nodular adrenocortical disease: clinical correlations and regulation of Wnt signaling","volume":"69","author":"Iliopoulos","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2023.102971_bib32","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1158\/2159-8290.CD-17-1271","article-title":"MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia","volume":"8","author":"Brown","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jbc.2023.102971_bib33","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood.2019004292","article-title":"Hematopoietic stem cells acquire survival advantage by loss of RUNX1 methylation identified in familial leukemia","volume":"136","author":"Matsumura","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2023.102971_bib34","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1476-4598-13-116","article-title":"Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia","volume":"13","author":"Haaland","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbc.2023.102971_bib35","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1038\/s41388-020-1253-0","article-title":"Deubiquitylase USP25 prevents degradation of BCR-ABL protein and ensures proliferation of Ph-positive leukemia cells","volume":"39","author":"Shibata","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2023.102971_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc1779","article-title":"Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer","volume":"6","author":"Minucci","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbc.2023.102971_bib37","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1158\/1541-7786.MCR-18-0922","article-title":"HDAC1 is a required cofactor of CBF\u03b2-SMMHC and a potential therapeutic target in inversion 16 acute myeloid leukemia","volume":"17","author":"Richter","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.jbc.2023.102971_bib38","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1158\/1078-0432.CCR-14-1290","article-title":"Selective inhibition of HDAC1 and HDAC2 as a potential therapeutic option for B-ALL","volume":"21","author":"Stubbs","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2023.102971_bib39","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1182\/blood.2019003538","article-title":"FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia","volume":"135","author":"Long","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2023.102971_bib40","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1182\/bloodadvances.2018020065","article-title":"Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia","volume":"2","author":"Maharaj","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.jbc.2023.102971_bib41","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/leu.2017.3","article-title":"HDAC3 activity is required for initiation of leukemogenesis in acute promyelocytic leukemia","volume":"31","author":"Mehdipour","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2023.102971_bib42","first-page":"2","article-title":"Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia","volume":"61","author":"Ferrara","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2023.102971_bib43","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI200111537","article-title":"Histone deacetylase inhibitors induce remission in transgenic models of therapy-resistant acute promyelocytic leukemia","volume":"108","author":"He","year":"2001","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jbc.2023.102971_bib44","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1038\/bcj.2015.38","article-title":"Rational combination treatment with histone deacetylase inhibitors and immunomodulatory drugs in multiple myeloma","volume":"5","author":"Hideshima","year":"2015","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.jbc.2023.102971_bib45","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1038\/leu.2017.130","article-title":"Targeting HDAC3, a new partner protein of AKT in the reversal of chemoresistance in acute myeloid leukemia via DNA damage response","volume":"31","author":"Long","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2023.102971_bib46","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1038\/onc.2015.293","article-title":"PTEN activation through K163 acetylation by inhibiting HDAC6 contributes to tumour inhibition","volume":"35","author":"Meng","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2023.102971_bib47","doi-asserted-by":"crossref","first-page":"ra80","DOI":"10.1126\/scisignal.2001462","article-title":"DNMT1 stability is regulated by proteins coordinating deubiquitination and acetylation-driven ubiquitination","volume":"3","author":"Du","year":"2010","journal-title":"Sci. Signal."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823001035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823001035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:37:49Z","timestamp":1758242269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925823001035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0021925823001035"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2023.102971","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetylation stabilizes the signaling protein WISP2 by preventing its degradation to suppress the progression of acute myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2023.102971","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"102971"}}